## Abstract Proteinoid microspheres (PM) are unusual polymers formed by the thermal condensation of amino acids. Although they have been studied for over 60 years, they are only now beginning to garner interest as controlled release agents. Although they are very biocompatible, it has been problema
Triggered release of small molecules from proteinoid microspheres
β Scribed by Stephen Quirk
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 259 KB
- Volume
- 91A
- Category
- Article
- ISSN
- 1549-3296
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Proteinoid microspheres (PM) are formed by the thermal condensation of amino acids. They have been useful to further evolutionary theory, as catalysts for some biochemical reactions, but they have not been overly useful as controlled delivery agents. It is possible however to construct PMs that contain organic small molecules in the interior space. This means that a PM could be used as a delivery agent, if a suitable method could be discovered to cause the release of the internal material. This report describes the formation of a PM that includes a molecular bridging agent that can be removed in a reducing environment. Removal of the bridge opens a hole or window in the PM that allows the interior material to escape. The rate at which the interior material is released from the PM can be controlled by the size of the window or by the reduction potential in the environment. These PMs can be used to temporally treat a variety of complications including wounds (chronic or acute) by delivering a sequestered reagent in a controlled manner and are advantageous in that amino acids are the primary delivery vehicle breakdown product. Β© 2008 Wiley Periodicals, Inc. J Biomed Mater Res, 2009
π SIMILAR VOLUMES
## Abstract In this study we formed and characterized dynamic hydrogel microspheres in which a protein conformational change was used to control microsphere volume changes and the release of an encapsulated drug. In particular, a specific biochemical ligand, trifluoperazine, induced calmodulin's na
Olanzapine was formulated as 10% (w/w) mixture with cutina to which stearic acid was added, ranging from 10% to 90% (w/w) of the total mass to control the drug release. The molten mixtures were processed by ultrasound-assisted spray-congealing technique, obtaining solid microspheres. The drug is sta
Chitosan microspheres were evaluated for sustained-release of recombinant human interleukin-2 (rIL-2) in this study. In addition, the effects of different formulation factors, such as chitosan and protein concentrations, the volume of sodium sulfate solution, addition technique of rIL-2, and presenc